Total Funding
59
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
31893
SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.
Acquired by 
Spur Therapeutics
Steven Zelenkofske: Chief Medical Officer
Kumar Dhanasekharan: Vice President & Technical OperationsPast Role: Amicus Therapeutics, Executive Director, Technical Development & Tech Transfer
About the Company
SwanBio Therapeutics is a developer of a therapeutic technology designed to deliver dramatic clinical efficacy for the treatment of neurological diseases. The company's technology focuses on the development and commercialisation of genetically defined therapies for the treatment of neurological disorders.
Women Founded
